Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03360890 |
|---|---|
| Brief Title: | Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors (iPRIME) |
| First Submitted : | November 20, 2017 |
| First Submitted that Met QC Criteria : | December 1, 2017 |
| First Posted : | December 4, 2017 |
| Last Update Submitted that Met QC Criteria : | February 14, 2023 |
| Last Update Posted : | February 16, 2023 |